Dernière minute
TRErzurum'da 7'nci kattan düşen halı, mağaza çalışanının başına isabet ettiTRBenzine zam pompaya yansıdı: Bazı illerde litre fiyatı 70 TL'ye yaklaştıTRBeşiktaş'ın UEFA Avrupa Ligi'ndeki Rakibi Midtjylland: Muhtemel 11'ler ve DetaylarTRABD ve Suudi Arabistan Arasında Barışçıl Nükleer İşbirliği Anlaşması İmzalandıTRYönetmen Ezel Akay ve kardeşi gözaltına alındıTRÖzgür Özel'in Yeni Parti Hazırlıkları CHP İçinde Gerilim YaratıyorTRNATO'da kurulması planlanan Savunma, Güvenlik ve Dayanıklılık Bankası'nın (DSRB) güvenlik mimarisine katkılarıTRMEB'in Yapay Zeka Destekli MEBİ Platformu Milyonlara UlaştıTRVeri Merkezlerinin Elektrik Tüketimi 2035'e Kadar Dört Katına ÇıkacakTRTÜİK'e Göre Tüketici Güven Endeksi Temmuz'da 89,8'e YükseldiTRErzurum'da 7'nci kattan düşen halı, mağaza çalışanının başına isabet ettiTRBenzine zam pompaya yansıdı: Bazı illerde litre fiyatı 70 TL'ye yaklaştıTRBeşiktaş'ın UEFA Avrupa Ligi'ndeki Rakibi Midtjylland: Muhtemel 11'ler ve DetaylarTRABD ve Suudi Arabistan Arasında Barışçıl Nükleer İşbirliği Anlaşması İmzalandıTRYönetmen Ezel Akay ve kardeşi gözaltına alındıTRÖzgür Özel'in Yeni Parti Hazırlıkları CHP İçinde Gerilim YaratıyorTRNATO'da kurulması planlanan Savunma, Güvenlik ve Dayanıklılık Bankası'nın (DSRB) güvenlik mimarisine katkılarıTRMEB'in Yapay Zeka Destekli MEBİ Platformu Milyonlara UlaştıTRVeri Merkezlerinin Elektrik Tüketimi 2035'e Kadar Dört Katına ÇıkacakTRTÜİK'e Göre Tüketici Güven Endeksi Temmuz'da 89,8'e Yükseldi
Newsgather

samsung biologics

Stable12 articles3 sourcesDernière mise à jour: il y a 3 jours
Sujets associésstrikesouth koreabiotechunionlabor disputecollective bargainingbiopharmaceuticallabor union

Derniers articles

Samsung Biologics Bids $1.8 Billion for PolyPeptide Group to Expand Peptide Therapeutics
En développement
Business·il y a 3 joursRésumé IA

Samsung Biologics Bids $1.8 Billion for PolyPeptide Group to Expand Peptide Therapeutics

South Korea's Samsung Biologics made an all-cash bid of 1.46 billion Swiss francs ($1.8 billion) for Switzerland's PolyPeptide Group. This acquisition, the largest biopharma M&A in South Korea's history, aims to diversify Samsung's portfolio into fast-growing peptide therapeutics, including obesity treatments, and expand its global footprint.

C
CNBC World
1 min de lecture
Samsung Biologics Union Agrees to Return to Negotiation Table After First-Ever Strike
En développement
Labor·03/05/2026Résumé IA

Samsung Biologics Union Agrees to Return to Negotiation Table After First-Ever Strike

Samsung Biologics union has agreed to return to negotiations on Monday under labor ministry mediation, after its first-ever strike entered day three. The union demands a 14% increase in base and performance pay, a 30 million won one-off cash incentive, and bonuses equal to 20% of annual operating profit. The company has proposed 6.2% and claims the walkout could cause at least 640 billion won in damage, equivalent to half its Q1 sales.

Y
Yonhap News
2 min de lecture
Samsung Biologics Union Agrees to Return to Negotiation Table After First-Ever Strike
En développement
Labor·03/05/2026Résumé IA

Samsung Biologics Union Agrees to Return to Negotiation Table After First-Ever Strike

Samsung Biologics union has agreed to return to negotiations on Monday under labor ministry mediation, after the first round of talks failed. The strike, the first in the company's history, is now in its third day with around 2,800 of 4,000 unionized workers walking out. The union demands a 14% increase in base and performance pay, a 30 million won one-off cash incentive per worker, and bonuses equal to 20% of annual operating profit. The company has proposed a 6.2% combined increase and claims the strike could cause at least 640 billion won in damage, equivalent to roughly half of its first-quarter sales.

Y
Yonhap News
1 min de lecture
Samsung Biologics Workers Begin First-Ever Strike, Company Warns of Potential $433M Losses
En développement
Business·01/05/2026Résumé IA

Samsung Biologics Workers Begin First-Ever Strike, Company Warns of Potential $433M Losses

Unionized workers at Samsung Biologics began a five-day general strike on May 1, marking the first labor action since the company's 2011 establishment. The union demands a 14% increase in base and performance pay, a 30 million won cash incentive, and bonuses equal to 20% of annual operating profit. The company proposed 6.2% and warned that full-scale strike losses could exceed 640 billion won ($433 million), roughly half of its Q1 sales. The strike has already forced cessation of some batch production of anticancer and HIV treatments, with current losses estimated at 150 billion won.

Y
Yonhap News
2 min de lecture
Samsung Biologics Workers Begin First-Ever Strike Over Wage Demands
En développement
Business·01/05/2026Résumé IA

Samsung Biologics Workers Begin First-Ever Strike Over Wage Demands

Unionized workers at Samsung Biologics launched a five-day general strike on May 1, 2026, marking the first labor walkout in the company's history since its 2011 establishment. The union demands a 14% increase in base and performance-related pay, a 30 million won one-off cash incentive, and bonuses equal to 20% of annual operating profit. The company has proposed 6.2% and warns losses could exceed 640 billion won ($433 million). Negotiations failed after 13 rounds despite a court injunction attempt.

Y
Yonhap News
1 min de lecture